Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 519606 | NSE Symbol : | ISIN : INE177M01013 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
11-Feb-2025	14-Feb-2025	Quarterly Results	INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the unaudited financial results for the quarter ended on December 2024 together with the Limited Review Report for the said period
04-Feb-2025	04-Feb-2025	Preferential Issue	Outcome of Meeting of the board of the director of the company held on February 04, 2025
03-Feb-2025	03-Feb-2025	Preferential Issue	Outcome of Meeting of Board of Directors of the company held on February 03, 2025
01-Feb-2025	01-Feb-2025	Preferential Issue	Outcome of the Meeting of Board of Directors of the Company held today i.e. February 01, 2025
28-Jan-2025	28-Jan-2025	Preferential Issue	Allotment of 44,00,000 (Forty-Four Lakh) out of 2,00,00,000 (Two Crore) Convertible Equity Warrants on Preferential Basis to the allottees.
24-Jan-2025	24-Jan-2025	Preferential Issue	Allotment of 20,00,000 (Twenty Lakh) out of 2,00,00,000 (Two Crore) Convertible Equity Warrants on Preferential Basis to the allottees.
10-Dec-2024	10-Dec-2024	Change in Auditors	Outcome of Board Meeting held on Tuesday, 10th December, 2024
18-Nov-2024	27-Nov-2024	Increase in Authorised Capital	INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/11/2024 inter alia to consider and approve Dear Sir/Madam Pursuant to Regulation 29 we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday November 23 2024 to consider and approve the agenda as mentioned in the attached pdf Further Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time (SEBI PIT Regulations) and the Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons (COC) framed by the Company we hereby inform the Exchanges that the trading window for buying selling pledging dealing trading etc. in the securities of the Company in any manner shall remain closed from Monday November 18 2024 till the completion of 48 hours after the declaration of outcome of the board meeting. INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/11/2024 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation 29 we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 23, 2024 to consider and approve the agenda as mentioned in the attached pdf Further, Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time (''SEBI PIT Regulations'') and the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons (''COC'') framed by the Company, we hereby inform the Exchanges that the trading window for buying, selling, pledging, dealing, trading etc. in the securities of the Company, in any manner, shall remain closed from Monday, November 18, 2024 till the completion of 48 hours after the declaration of outcome of the board meeting. (As Per BSE Announcement Dated on 24.11.2024) With reference to above subject and in compliance with Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e., Wednesday, 27th November 2024, at 7: 30 p.m. and concluded on 9:15 p.m. inter alia considered and approved the agenda items as attached in the file herewith. Disclosure under Regulation 30 of SEBI(LODR), 2015 regarding reconstitution of the Committees of the Board with immediate effect. (As Per BSE Announcement dated on 27.11.2024)
16-Nov-2024	16-Nov-2024	Change in Directors	Outcome of Board Meeting under Regulation 30 of SEBI(LODR), 2015 The Board at its meeting held today i.e. on 16th November, 2024 noted and accepted the resignation as tendered by Mr. Chintan A .Shah from the post of the Managing Director of the company wef 16th November, 2024 Consequently, he ceased to be a KMP under the provisions of Companies Act 2013 and Reg 30(2) of SEBI(LODR), 2015
12-Oct-2024	18-Oct-2024	Quarterly Results	INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2024 inter alia to consider and approve the financial results for the quarter and half year ended 30th September 2024 together with the Limited Review Report thereon. Outcome of Board Meeting held today on 18th October, 2024 Financial Results for the quarter ended on 30th September, 2024 alongwith the Limited Review Report thereon. (As per BSE Announcement Dated on 18/10/2024)
06-Aug-2024	12-Aug-2024	Quarterly Results	INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve With reference to captioned subject kindly be informed that the meeting of the board of directors of company is scheduled on Monday 12th August 2024; interalia to approve the unaudited financial results for the quarter ended on 30th June 2024 together with the Limited Review Report for the said period and to discuss any other item as tabled. The trading window which was closed from 1st July 2024 will be opened 48 hours after the declaration of financial results i.e. on 15th August 2024 Outcome of Board Meeting under Regulation 30 of SEBI(LODR), 2015 (As per BSE Announcement dated on 12/08/2024)
06-Aug-2024	06-Aug-2024	AGM	Outcome of the Board Meeting held today i.e. on 6th August, 2024 under Regulation 30 of SEBI(LODR), Regulations, 2015.
20-Apr-2024	26-Apr-2024	Quarterly Results	INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 ,inter alia, to consider and approve the audited financial results of the company for the quarter and year ended 31st March, 2024 and any other agenda items as tabled. Outcome of Board Meeting for the meeting held today i.e. Friday, 26th April, 2024 Revised outcome submitted as there was a human error in selecting time of Board Meeting while filing the Outcome of Board Meeting. Kindly take a note of above. (As per BSE Announcement Dated on 26/04/2024)
01-Feb-2024	08-Feb-2024	Quarterly Results	INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the unaudited financial results for the quarter ended on 31st December 2024 together with the Limited Review Report on the same. KFA the Outcome of Board Meeting held today i.e on 8th February, 2024 (As Per BSE Announcement dated on 08.02.2024) Announcement under Regulation 30 for the appointment of an Internal Auditor. (As Per BSE Announcement Dated on 09/02/2024)
24-Oct-2023	31-Oct-2023	Quarterly Results	INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 ,inter alia, to consider and approve the unaudited financials results for the quarter and nine months ended on 30th September, 2023 Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby report the outcome of the meeting of the Board of Directors held today, i.e. Tuesday, 31st October, 2023, Financial Results together with the Limited Review Report by Auditors for the quarter and six months ended 30th September, 2023 (As per BSE Announcement Dated on 31/10/2023) Announcement under Regulation 30 (As per BSE Announcement Dated on 01/11/2023)

1 2 3

LOGIN HERE

Integrated Proteins Ltd

Board Meeting